Frontiers in Pharmacology | Pharmacology of Anti-Cancer Drugs

Original Research

Published on 20 Mar 2025

A novel ubiquitin-related genes-based signature demonstrated values in prognostic prediction, immune landscape sculpture and therapeutic options in laryngeal cancer

in Pharmacology of Anti-Cancer Drugs

Lu Liu
Bing Wang
Xiaoya Ma
Lei Tan
Xudong Wei

Frontiers in Pharmacology

doi 10.3389/fphar.2025.1513948

1,227 views

Correction

Published on 20 Mar 2025

Corrigendum: Astragalus–Scorpion drug pair inhibits the development of prostate cancer by regulating GDPD4-2/PI3K/AKT/mTOR pathway and autophagy

in Pharmacology of Anti-Cancer Drugs

Xujun You
Yongrong Wu
Qixin Li
Wen Sheng
Qing Zhou
Wei Fu

Frontiers in Pharmacology

doi 10.3389/fphar.2025.1417603

805 views

Original Research

Published on 19 Mar 2025

Cyperotundone promotes chemosensitivity of breast cancer via SRSF1

in Pharmacology of Anti-Cancer Drugs

Chao Li
Lin Wang
Zhaoyun Liu
Xinzhao Wang
Luhao Sun
Xiang Song
Zhiyong Yu

Frontiers in Pharmacology

doi 10.3389/fphar.2025.1510161

946 views

Systematic Review

Published on 19 Mar 2025

Immune checkpoint inhibitors-induced pancreatitis: a systematic review and real-world pharmacovigilance analysis

in Pharmacology of Anti-Cancer Drugs

Wei Fang
Huanping Wang
Xiaoran Zhang
Hongxia Zhu
Wei Yan
Yang Gao

Frontiers in Pharmacology

doi 10.3389/fphar.2025.1426847

2,017 views

Original Research

Published on 19 Mar 2025

The real-world analysis of adverse events with azacitidine: a pharmacovigilance study based on the FAERS and WHO-VigiAccess databases

in Pharmacology of Anti-Cancer Drugs

Zhaorui Wang
Linlin Guo
Youfu He
Baiquan Zhang
Yang Wang
Juan Ding

Frontiers in Pharmacology

doi 10.3389/fphar.2025.1555838

2,275 views

Original Research

Published on 19 Mar 2025

Unravelling the antitumor mechanism of Ocoxin through cancer cell genomics

in Pharmacology of Anti-Cancer Drugs

Iera Hernandez-Unzueta
Uxue Telleria-Gonzalez
Ana María Aransay
José Ezequiel Martin Rodriguez
Eduardo Sanz
Joana Márquez

Frontiers in Pharmacology

doi 10.3389/fphar.2025.1540217

1,245 views

Original Research

Published on 18 Mar 2025

Characteristic analysis of adverse reactions of histone deacetylase inhibitors based on WHO-VigiAccess

in Pharmacology of Anti-Cancer Drugs

Tongnan Yin
Yuyu Liu
Chenwen Li
Xinran Feng
Yumeng Lin
Zhongyu Qu

Frontiers in Pharmacology

doi 10.3389/fphar.2025.1563797

848 views

Editorial

Published on 17 Mar 2025

Editorial: Drugs and methods that enhance the anti-cancer efficacy of artesunate

in Pharmacology of Anti-Cancer Drugs

Tuğçenur Uzun

Frontiers in Pharmacology

doi 10.3389/fphar.2025.1566700

974 views

Original Research

Published on 17 Mar 2025

Onvansertib exhibits anti-proliferative and anti-invasive effects in endometrial cancer

in Pharmacology of Anti-Cancer Drugs

Nikita Sinha
Xiaochang Shen
Jennifer Haag
Shuning Chen
Haomeng Zhang
Catherine John
Wenchuan Sun
Michael Emanuele
Chunxiao Zhou
Victoria Bae-Jump

Frontiers in Pharmacology

doi 10.3389/fphar.2025.1545038

1,123 views

Original Research

Published on 17 Mar 2025

Metformin upregulates circadian gene PER2 to inhibit growth and enhance the sensitivity of glioblastoma cell lines to radiotherapy via SIRT2/G6PD pathway

in Pharmacology of Anti-Cancer Drugs

Hailiang Li
Zheng Ma
Wanfu Yang
Yifan Zhang
Jinping Sun
Haifeng Jiang
Faxuan Wang
Li Hou
Hechun Xia

Frontiers in Pharmacology

doi 10.3389/fphar.2025.1563865

1,795 views

Review

Published on 17 Mar 2025

Potential role of lactylation in intrinsic immune pathways in lung cancer

in Pharmacology of Anti-Cancer Drugs

Mengdie Huang
Ye Jin
Dandan Zhao
Xingren Liu

Frontiers in Pharmacology

doi 10.3389/fphar.2025.1533493

2,928 views

Review

Published on 17 Mar 2025

Strategies for salvage therapy post CAR-T therapy failure in refractory/relapsed multiple myeloma patients

in Pharmacology of Anti-Cancer Drugs

Chao Min
Xiong Zhong
Yue Cui
Hanfu Zhang
Qingming Wang

Frontiers in Pharmacology

doi 10.3389/fphar.2025.1515555

1,714 views

Correction

Published on 14 Mar 2025

Corrigendum: LINC-PINT suppresses cisplatin resistance in gastric cancer by inhibiting autophagy activation via epigenetic silencing of ATG5 by EZH2

in Pharmacology of Anti-Cancer Drugs

Cheng Zhang
Tong Kang
Xinyi Wang
Jizhao Wang
Lin Liu
Jiawei Zhang
Xu Liu
Rong Li
Jiansheng Wang
Jia Zhang

Frontiers in Pharmacology

doi 10.3389/fphar.2025.1424320

700 views

Original Research

Published on 14 Mar 2025

SB218078 inhibits angiogenesis and epithelial-mesenchymal transition in breast cancer

in Pharmacology of Anti-Cancer Drugs

Qianxue Wu
Jiawei Xu
Xin Tang
Jin Yu
Benhua Li
Jun Yang
Xiang Zhang

Frontiers in Pharmacology

doi 10.3389/fphar.2025.1552707

930 views

Original Research

Accepted on 13 Mar 2025

Hypothyroidism as a Predictive Biomarker for Survival Benefits in Advanced Colorectal Cancer Patients Treated with Apatinib-Based Therapy

in Pharmacology of Anti-Cancer Drugs

Yi Zhong
Jingyi Wu
Fang Guo
Shuang Dong
Xiaoyu Li
Xianmin Zhu
Yuze Zhu
Kun Wang
Yuanxiang Li
Sheng Hu

Frontiers in Pharmacology

doi 10.3389/fphar.2025.1506830

204 views

Systematic Review

Published on 13 Mar 2025

Adverse kidney related events following targeted therapies in lung cancer: a systematic review and network meta-analysis of randomized controlled trials

in Pharmacology of Anti-Cancer Drugs

Song Ren
Wei Wang
Xiaoxiu Yao
Wenyan Fang
Guisen Li
Yunlin Feng
Min Xia

Frontiers in Pharmacology

doi 10.3389/fphar.2025.1511171

1,177 views